 Andrew Wolf
Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Sclerosis | 4 | 2024 | 455 | 1.290 |
Why?
| | Education, Nursing | 2 | 2018 | 97 | 1.050 |
Why?
| | Students, Nursing | 2 | 2018 | 88 | 1.050 |
Why?
| | Medical Tourism | 1 | 2023 | 8 | 0.840 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2024 | 76 | 0.790 |
Why?
| | Meningitis | 1 | 2023 | 79 | 0.760 |
Why?
| | Mycobacterium abscessus | 1 | 2023 | 117 | 0.730 |
Why?
| | Alzheimer Disease | 5 | 2016 | 560 | 0.720 |
Why?
| | Writing | 1 | 2022 | 95 | 0.690 |
Why?
| | Serum Sickness | 1 | 2019 | 6 | 0.640 |
Why?
| | Rituximab | 1 | 2019 | 176 | 0.590 |
Why?
| | Videotape Recording | 1 | 2018 | 35 | 0.590 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 363 | 0.580 |
Why?
| | Immunologic Factors | 1 | 2019 | 236 | 0.540 |
Why?
| | Superior Colliculi | 1 | 2015 | 40 | 0.460 |
Why?
| | Internet | 1 | 2018 | 655 | 0.430 |
Why?
| | Apolipoproteins E | 1 | 2012 | 83 | 0.390 |
Why?
| | Neuromyelitis Optica | 2 | 2024 | 132 | 0.380 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2012 | 54 | 0.370 |
Why?
| | Mitochondrial Diseases | 1 | 2012 | 91 | 0.350 |
Why?
| | Models, Neurological | 1 | 2012 | 242 | 0.340 |
Why?
| | Energy Metabolism | 2 | 2016 | 922 | 0.340 |
Why?
| | Motor Activity | 1 | 2015 | 718 | 0.330 |
Why?
| | Strabismus | 2 | 2007 | 29 | 0.320 |
Why?
| | Decision Making | 1 | 2015 | 900 | 0.280 |
Why?
| | Orbital Myositis | 1 | 2007 | 1 | 0.270 |
Why?
| | Dietary Supplements | 1 | 2012 | 561 | 0.270 |
Why?
| | Oculomotor Muscles | 1 | 2007 | 40 | 0.260 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2007 | 58 | 0.260 |
Why?
| | Albinism, Ocular | 1 | 2005 | 1 | 0.240 |
Why?
| | Albinism, Oculocutaneous | 1 | 2005 | 5 | 0.240 |
Why?
| | Nystagmus, Pathologic | 1 | 2005 | 13 | 0.240 |
Why?
| | Creutzfeldt-Jakob Syndrome | 1 | 2025 | 19 | 0.240 |
Why?
| | Human Growth Hormone | 1 | 2025 | 48 | 0.230 |
Why?
| | Aquaporin 4 | 1 | 2024 | 94 | 0.220 |
Why?
| | Apolipoprotein E4 | 2 | 2016 | 37 | 0.200 |
Why?
| | Gyrus Cinguli | 2 | 2016 | 86 | 0.200 |
Why?
| | Feedback | 1 | 2022 | 173 | 0.180 |
Why?
| | Humans | 20 | 2025 | 137585 | 0.170 |
Why?
| | Brain | 1 | 2012 | 2668 | 0.170 |
Why?
| | Recurrence | 1 | 2024 | 1060 | 0.170 |
Why?
| | Visual Acuity | 2 | 2016 | 356 | 0.160 |
Why?
| | Stem Cells | 1 | 2023 | 594 | 0.150 |
Why?
| | Immunosuppressive Agents | 1 | 2024 | 890 | 0.150 |
Why?
| | Faculty, Nursing | 1 | 2018 | 34 | 0.140 |
Why?
| | Education, Distance | 1 | 2018 | 50 | 0.140 |
Why?
| | Personal Satisfaction | 1 | 2018 | 207 | 0.130 |
Why?
| | Visual Cortex | 1 | 2016 | 70 | 0.120 |
Why?
| | Eye | 1 | 2016 | 108 | 0.120 |
Why?
| | Spatial Behavior | 1 | 2015 | 26 | 0.120 |
Why?
| | Vision Disorders | 1 | 2016 | 142 | 0.120 |
Why?
| | Neurosurgical Procedures | 2 | 2014 | 197 | 0.120 |
Why?
| | Postoperative Complications | 1 | 2007 | 2654 | 0.120 |
Why?
| | Electron Transport Complex IV | 2 | 2012 | 60 | 0.110 |
Why?
| | Learning | 1 | 2018 | 409 | 0.110 |
Why?
| | Neuroimaging | 1 | 2016 | 259 | 0.110 |
Why?
| | Oligodendroglioma | 1 | 2013 | 15 | 0.110 |
Why?
| | Vision Screening | 1 | 2013 | 9 | 0.110 |
Why?
| | Neural Pathways | 1 | 2015 | 295 | 0.100 |
Why?
| | Evoked Potentials, Visual | 1 | 2013 | 35 | 0.100 |
Why?
| | Retinal Neoplasms | 1 | 2013 | 25 | 0.100 |
Why?
| | Retinoblastoma | 1 | 2013 | 32 | 0.100 |
Why?
| | Pilot Projects | 1 | 2018 | 1710 | 0.100 |
Why?
| | Female | 12 | 2025 | 73304 | 0.100 |
Why?
| | Synaptophysin | 1 | 2012 | 14 | 0.090 |
Why?
| | Radionuclide Imaging | 1 | 2012 | 118 | 0.090 |
Why?
| | Aged | 5 | 2024 | 23961 | 0.090 |
Why?
| | Maze Learning | 1 | 2012 | 103 | 0.090 |
Why?
| | Amyloidosis | 1 | 2012 | 42 | 0.090 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2013 | 327 | 0.090 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2012 | 100 | 0.090 |
Why?
| | Radiopharmaceuticals | 1 | 2012 | 178 | 0.090 |
Why?
| | tau Proteins | 1 | 2012 | 90 | 0.090 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2012 | 135 | 0.090 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2013 | 752 | 0.090 |
Why?
| | Retrospective Studies | 6 | 2024 | 15657 | 0.080 |
Why?
| | Glioblastoma | 1 | 2014 | 345 | 0.080 |
Why?
| | Genetic Carrier Screening | 1 | 2010 | 28 | 0.080 |
Why?
| | Plant Extracts | 1 | 2012 | 202 | 0.080 |
Why?
| | Neoplasms | 1 | 2024 | 2671 | 0.080 |
Why?
| | Radiosurgery | 1 | 2013 | 344 | 0.080 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 852 | 0.080 |
Why?
| | Reoperation | 2 | 2014 | 573 | 0.080 |
Why?
| | Psychomotor Performance | 1 | 2012 | 309 | 0.080 |
Why?
| | Treatment Outcome | 5 | 2024 | 10811 | 0.070 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1738 | 0.070 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2014 | 1079 | 0.070 |
Why?
| | Male | 9 | 2024 | 67762 | 0.070 |
Why?
| | Prednisolone | 1 | 2007 | 83 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2016 | 2607 | 0.060 |
Why?
| | Sex Characteristics | 1 | 2012 | 762 | 0.060 |
Why?
| | Postoperative Period | 1 | 2007 | 342 | 0.060 |
Why?
| | Vision, Binocular | 1 | 2005 | 21 | 0.060 |
Why?
| | Middle Aged | 5 | 2025 | 33479 | 0.060 |
Why?
| | Adult | 7 | 2024 | 37929 | 0.060 |
Why?
| | Iatrogenic Disease | 1 | 2025 | 67 | 0.060 |
Why?
| | Brain Neoplasms | 1 | 2014 | 1238 | 0.060 |
Why?
| | Cadaver | 1 | 2025 | 296 | 0.050 |
Why?
| | Cognition | 1 | 2012 | 1153 | 0.050 |
Why?
| | Adolescent | 4 | 2024 | 21513 | 0.050 |
Why?
| | Mitochondria | 1 | 2010 | 948 | 0.050 |
Why?
| | Myelin-Oligodendrocyte Glycoprotein | 1 | 2023 | 51 | 0.050 |
Why?
| | Glucocorticoids | 1 | 2007 | 594 | 0.050 |
Why?
| | Animals | 2 | 2015 | 36940 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 1 | 2010 | 2426 | 0.040 |
Why?
| | Mice, Inbred C57BL | 1 | 2012 | 5757 | 0.040 |
Why?
| | Inflammation | 1 | 2012 | 2837 | 0.040 |
Why?
| | United States | 3 | 2025 | 14841 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2023 | 893 | 0.040 |
Why?
| | Incidence | 1 | 2024 | 2804 | 0.040 |
Why?
| | Prevalence | 1 | 2024 | 2734 | 0.030 |
Why?
| | Young Adult | 3 | 2024 | 13209 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2007 | 2691 | 0.030 |
Why?
| | Amino Acid Transport System X-AG | 1 | 2016 | 4 | 0.030 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2016 | 22 | 0.030 |
Why?
| | Hexokinase | 1 | 2016 | 19 | 0.030 |
Why?
| | Disease Progression | 2 | 2014 | 2757 | 0.030 |
Why?
| | Autoantibodies | 1 | 2023 | 1496 | 0.030 |
Why?
| | Mice | 1 | 2012 | 17787 | 0.030 |
Why?
| | Tissue Fixation | 1 | 2013 | 36 | 0.030 |
Why?
| | Mitochondrial Proteins | 1 | 2016 | 257 | 0.030 |
Why?
| | Infusions, Intra-Arterial | 1 | 2013 | 59 | 0.030 |
Why?
| | Cryotherapy | 1 | 2013 | 17 | 0.030 |
Why?
| | Microsurgery | 1 | 2013 | 75 | 0.030 |
Why?
| | Risk Factors | 1 | 2007 | 10388 | 0.020 |
Why?
| | Hyperthermia, Induced | 1 | 2013 | 116 | 0.020 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2013 | 220 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2013 | 686 | 0.020 |
Why?
| | Meningioma | 1 | 2013 | 91 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2013 | 889 | 0.020 |
Why?
| | Nervous System Diseases | 1 | 2013 | 266 | 0.020 |
Why?
| | Child, Preschool | 1 | 2005 | 11074 | 0.020 |
Why?
| | Survival Analysis | 1 | 2013 | 1325 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2013 | 1236 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2016 | 2833 | 0.020 |
Why?
| | Alleles | 1 | 2010 | 891 | 0.020 |
Why?
| | Child | 1 | 2005 | 21935 | 0.010 |
Why?
| | Prognosis | 1 | 2014 | 4030 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2013 | 5131 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2013 | 2129 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2014 | 7635 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2013 | 3566 | 0.010 |
Why?
| | Infant | 1 | 2013 | 9465 | 0.010 |
Why?
|
|
Wolf's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|